Medical Polyoxymethylene Market Is Expected To Reach Revenue Of USD 253.5 Mn By 2033, at 7.4 % CAGR: Dimension Market Research
22 mai 2024 12h49 HE
|
Dimension Market Research
New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview The Medical Polyoxymethylene Market size is expected to reach USD 133.6 million by 2024 and is further anticipated to value USD 253.5...
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
20 mai 2024 16h05 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...
Southeast Detox GA: Award Winning Suboxone Treatment Center in Rome, GA
16 mai 2024 09h00 HE
|
Southeast Detox GA
Rome, GA, May 16, 2024 (GLOBE NEWSWIRE) -- Southeast Detox GA, a leading inpatient alcohol and drug addiction rehab center, is excited to announce that its Rome Georgia in-patient detox facility has...
Venture Partnership: Leading Medical Recruitment Agency Secures Coveted Framework Award
15 mai 2024 09h00 HE
|
Venture Partnership
Uxbridge, England, May 15, 2024 (GLOBE NEWSWIRE) -- Venture Partnership, a leading recruitment agency focused on providing permanent and locum doctor staffing solutions to the primary, acute, and...
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
14 mai 2024 16h15 HE
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
13 mai 2024 20h22 HE
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
09 mai 2024 14h51 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
RTI Connext® Named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program
09 mai 2024 10h00 HE
|
Real-Time Innovations (RTI)
RTI Connext® named “Best Overall Connected Healthcare Solution” in 8th Annual MedTech Breakthrough Awards Program.
Kidney Dialysis Market is expected to reach a revenue of USD 143.8 Bn by 2032, at 6.2% CAGR: Dimension Market Research
07 mai 2024 12h23 HE
|
Dimension Market Research
New York, May 07, 2024 (GLOBE NEWSWIRE) -- Overview The Global Kidney Dialysis Market size reached USD 83.4 billion in 2023 and is further anticipated to reach USD 143.8 billion by 2032 according...
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
03 mai 2024 07h00 HE
|
GH Research PLC
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1...